Posted on February 10, 2010.
"On the growth path-diagnosis and pathological testing market in India" "On the growth path Diagnostics and pathology testing market in India"
The Indian industry growth of health
The health sector in India is growing at a rapid pace and it is ready to become a dominant participant in the Indian economy. According to a report by Yes Bank and ASSOCHAM, industry Indian Health care is estimated to grow at 23% per year to 77 billion dollars by 2012 compared to the current 35 billion. The sector grew at a rate of 9.3% from the year 2000-2009.
In sum, diagnosis and pathology represent $ 2.5 billion in 2012, more than double its current size is estimated at 1 billion dollars. The growth in the segment should be driven by industry consolidation and increasing insurance penetration among the population. Health facilities, including hospitals and private sector base, about which the health sector is focused, continue to contribute over 70% of the whole sector and to reach a figure of 54.7 billion dollars by 2012
According to McKinsey, the Indian healthcare market is expected to grow at a rate of 10-12 per cent per annum This is driven by strong local demand and the growing population. With an average household consumption should increase by more than 7 percent per year, annual health spending should grow by 10 percent and the number of insured is likely to increase from 100 million to 220 million. strong population of India, it is an important player in this industry. According to the regulation of insurance and Development Authority, the health of Indians has the potential to show the same exponential growth that the software industries and pharmaceuticals have shown over the past decade. Only 10 percent of the market potential has been tapped till date. This is indicative of the potential high-growth market of health care for Indians.
Recent years have seen an increase in the purchasing power of the middle class. With a sedentary lifestyle and erratic urban expansion and the average upper middle class of India, health has become an important component of everyone's life. The health care spending is rising with increasing self-awareness and availability of health care facilities upscale with the arrival of private players. According to ICRA 2005 report on the healthcare industry in India, India spends 5.10 per cent of its GDP on health. India's expenditure on health as a percentage of GDP, is among the highest for developing countries. India is considered as the preferred destination for quality healthcare solutions because of the major cost advantage over western countries.
The growing sector, pathology and diagnostic market in India
The diagnosis and pathology testing market in India is one of the most lucrative markets in the world. The market has seen robust growth over the past few years behind the prevalence of the disease and the growing consumer awareness. There are two main market segments of diagnoses:
1) Laboratories Pathological kits 2) and diagnostic reagents
The two sections above provide strong growth potential, both in the domestic market and as a privileged center for clinical trials and outsourcing from Western countries.
Pathological Laboratory activities
The turnover of diagnostic segments should increase at a CAGR of 20% during the period 2010-2012. With growing awareness among people to have a healthy lifestyle, the diagnostic market in India will experience strong growth in coming years. The country is experiencing strong growth in segments biochemical and molecular diagnostics.
Pathologists.